Search for: "ACTAVIS"
Results 301 - 320
of 1,005
Sort by Relevance
|
Sort by Date
10 Aug 2017, 9:43 am
Having been distracted from the world of IP by his daughter's recent wedding, there has been some delay in this GuestKat's posting of the third instalment of his commentary on Eli Lilly v Actavis UK, [2017] UKSC 48. [read post]
8 Aug 2017, 12:10 pm
. | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany | Sunday Surprises Never Too Late 154 [week ending Sunday 2 July] I Book… [read post]
23 Jul 2017, 9:43 pm
The UK Supreme Court's judgment in Lilly v Actavis has profound implications for the scope of protection provided by patent claims in the UK. [read post]
21 Jul 2017, 3:14 am
The post discusses the reasons for the unanimous conclusions reached in the Eli Lilly v Actavis UK [2017] UKSC 48 case.As the news about Google’s paid research was on all the headlines all around the World, Kat Nicola gave her own critical insight on the news on: The Smoking Gun - Is IP research the next tobacco scandal? [read post]
17 Jul 2017, 3:39 pm
Here as promised is the second part of this GuestKat's commentary on Eli Lilly v Actavis UK [2017] UKSC 48, which promises to have much ink spilled and air of various temperatures emitted on its behalf in the coming weeks, months and years. [read post]
15 Jul 2017, 5:11 am
BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patentThe on-going saga between Eli Lilly and Actavis regarding Lilly's pemetrexed disodium product has kept the English courts busy for years. [read post]
13 Jul 2017, 11:10 am
The Middlesex Guildhall, Site of the Supreme Court Photo Christine SmithCreative Commons Attribution Share-Alike 4.0 International LicenceSource Wikipedia Jane Lambert Supreme Court (Lords Neuberger, Mance, Clarke, Sumption and Hodge) Eli Lilly v Actavis UK Ltd and others [2017] UKSC 48 (12 July 2017) What the Appeal was about The pharmaceutical company Eli Lilly and Co (" [read post]
13 Jul 2017, 8:47 am
On that basis, Actavis’ products did not directly infringe as in no sensible way could Actavis’ products be said to fall within the expression “pemetrexed disodium”. [read post]
13 Jul 2017, 8:47 am
On that basis, Actavis’ products did not directly infringe as in no sensible way could Actavis’ products be said to fall within the expression “pemetrexed disodium”. [read post]
12 Jul 2017, 1:34 pm
It is here - the Supreme Court's decision in Eli Lilly v Actavis UK [2017] UKSC 48. [read post]
12 Jul 2017, 10:14 am
It will suffice to recall that the case stemmed from a complaint filed by Actavis against Eli Lilly in England seeking a declaration of non-infringement affecting not only England but also France, Italy and Spain. [read post]
12 Jul 2017, 10:14 am
It will suffice to recall that the case stemmed from a complaint filed by Actavis against Eli Lilly in England seeking a declaration of non-infringement affecting not only England but also France, Italy and Spain. [read post]
12 Jul 2017, 7:59 am
Eli Lilly v Actavis UK [2017] UKSC 48This is an important case about whether drugs manufactured by Actavis infringe a European patent of Lilly. [read post]
12 Jul 2017, 2:30 am
The Supreme Court unanimously allowed Lilly’s appeal, holding that the Actavis products would infringe the Patent in the United Kingdom, and in France, Italy and Spain. [read post]
11 Jul 2017, 9:26 pm
Actavis, finding that although so-called reverse payment settlement agreements were not per se antitrust violations in cases brought against generic drug makers by under 35 U.S.C. [read post]
10 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
7 Jul 2017, 8:53 am
The Court has also dismissed Actavis’ cross-appeal and held that Actavis’ products would also indirectly infringe Eli Lilly’s patent to the extent held by the Court of Appeal. [read post]
7 Jul 2017, 8:53 am
The Court has also dismissed Actavis’ cross-appeal and held that Actavis’ products would also indirectly infringe Eli Lilly’s patent to the extent held by the Court of Appeal. [read post]
7 Jul 2017, 4:12 am
In light of those undertakings, it seems that Actavis/Teva's launch plans have been scuppered.For a summary of the litigation see this IPKat report here. [read post]
3 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
